NeuroPace Inc (NPCE)
13.34
-0.13
(-0.97%)
USD |
NASDAQ |
May 07, 12:06
NeuroPace Revenue (TTM): 65.42M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.42M |
| September 30, 2023 | 60.20M |
| June 30, 2023 | 54.93M |
| March 31, 2023 | 48.62M |
| December 31, 2022 | 45.52M |
| September 30, 2022 | 43.73M |
| June 30, 2022 | 42.91M |
| Date | Value |
|---|---|
| March 31, 2022 | 45.34M |
| December 31, 2021 | 45.18M |
| September 30, 2021 | 44.94M |
| June 30, 2021 | 47.37M |
| March 31, 2021 | 42.38M |
| December 31, 2020 | 41.14M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
41.14M
Minimum
Dec 2020
65.42M
Maximum
Dec 2023
48.28M
Average
45.34M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Ainos Inc | 0.1221M |
| OpGen Inc | 3.070M |
| Zomedica Corp | 25.19M |
| LENSAR Inc | 42.16M |
| Eargo Inc (DELISTED) | 41.11M |